Did intense adverse media publicity impact on prescribing of paroxetine and the notification of suspected adverse drug reactions? Analysis of routine databases, 2001–2004
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Aim: To document the impact on clinical practice in England of media attention around possible adverse effects of paroxetine. Design: Analysis of national selective serotonin reuptake inhibitor (SSRI) prescribing trends and yellow‐card adverse drug reaction reports, 2001–2004. Results: From a steady state in 2001, paroxetine prescribing declined sharply from April 2002, coinciding with a USA regulatory action; the subsequent decline in paroxetine prescribing was 1.87% per month (95% confidence interval − 2.06, −1.68). Other SSRI prescribing increased by 1% per month until a major UK review of SSRIs in children in December 2003, after which prescribing plateaued. Media publicity was associated with short‐term peaks in yellow‐card reports related to paroxetine. Conclusion: Falls in paroxetine and other SSRI prescribing in the UK coincided, respectively, with regulatory communications from the USA and the UK, but associations may have noncausal or other explanations. Reports of adverse reactions to paroxetine appeared to increase after adverse media publicity about the drug.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PRICE, J. S., WALLER, P. C., WOOD, S. M., & MACKAY, A. V. P. (1996) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1996.00498.x · Cited by 171
More cases of paroxetine withdrawal syndrome
Pacheco, L., Malo, P., Aragues, E., & Etxebeste, M. (1996) · British Journal of Psychiatry · doi:10.1192/bjp.169.3.384a · Cited by 21
Cited by
Thomas, K. H., Martin, R. M., Davies, N. M., Metcalfe, C., Windmeijer, F., & Gunnell, D. (2013) · BMJ · doi:10.1136/bmj.f5704 · Cited by 119
Self-citationFaasse, K., Gamble, G., Cundy, T., & Petrie, K. J. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001607 · Cited by 83
“Media coverage has previously been shown to increase reports of adverse drug reactions.(29) Medsafe, New Zealand’s medicines and medical devices monitoring agency, has noted that the Eltroxin”
McCrea, R. L., Sammon, C. J., Nazareth, I., & Petersen, I. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.115.166975 · Cited by 40
Antidepressants, withdrawal, and addiction; where are we now?
Jauhar, S., Hayes, J., Goodwin, G. M., Baldwin, D. S., Cowen, P. J., & Nutt, D. J. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119845799 · Cited by 31
“Many clinicians report not prescribing paroxetine because of potential side effects and withdrawal problems (Martin et al., 2006).”
Dubrall, D., Fekete, S., Leitzen, S., Paschke, L. M., Romanos, M., Schmid, M., Gerlach, M., & Sachs, B. (2023) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-023-00664-z · Cited by 15
“As also seen in prior analyses shortly before the warnings [5, 6], the increased number of the US and EU reports in the warning period in our analysis may be related to the media attention dedicated to the reports [24] and warnings themselves [1, 2].”
BackgroundResult
Metadata
- Authors
- Martin, R. M., May, M., & Gunnell, D.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2005-11-07
- Volume
- 61
- Issue
- 2
- Pages
- 224-228
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W2090673567
- Cited by
- 51
- References
- 2
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Did intense adverse media publicity impact on prescribing of paroxetine and the notification of suspected adverse drug reactions? Analysis of routine databases, 2001–2004. https://app.cochat.ai/papers/10.1111/j.1365-2125.2005.02527.x
- The paper
- Martin, R. M., May, M., & Gunnell, D. (2006). Did intense adverse media publicity impact on prescribing of paroxetine and the notification of suspected adverse drug reactions? Analysis of routine databases, 2001–2004. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.2005.02527.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.